| Frederick H Albrink, MD | |
|
1322 Spring St, Jeffersonville, IN 47130-3706 | |
| (812) 285-6000 | |
| (812) 285-6010 |
| Full Name | Frederick H Albrink |
|---|---|
| Gender | Male |
| Speciality | Radiology - Radiation Oncology |
| Location | 1322 Spring St, Jeffersonville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386632248 | NPI | - | NPPES |
| 64878333 | Medicaid | KY | |
| P00204016 | Other | IN | RR MCR |
| 200427190 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 01037027A (Indiana) | Primary |
| 2085R0001X | Radiology - Radiation Oncology | 25860 (Kentucky) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Frederick H Albrink, MD 1322 Spring St, Jeffersonville, IN 47130-3706 Ph: (812) 285-6000 | Frederick H Albrink, MD 1322 Spring St, Jeffersonville, IN 47130-3706 Ph: (812) 285-6000 |
News Archive
Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
The current leading method to assess the presence of viruses and other biological markers of disease is effective but large and expensive. It is prohibitively difficult for use in many situations, especially due to certain economic and geographic factors.
Business Intelligence Associates, Inc. (BIA), today announces the long-anticipated release of its enterprise legal software product, Solis™, which is a complete in-house solution providing a defensible and automated system for legal hold, data collections, and early case assessment.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for BYDUREON™ (exenatide for extended-release injectable suspension).
› Verified 2 days ago
Dr. Edsel S. Reed Jr., M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1214 Spring St, Suite 2, Jeffersonville, IN 47130 Phone: 812-283-5950 Fax: 812-285-5439 | |
Dr. Lawrence David Hochman, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1322 Spring St, Jeffersonville, IN 47130 Phone: 812-282-3899 Fax: 812-282-4172 | |
Scott Meacham Duncan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1214 Spring St, Suite 2, Jeffersonville, IN 47130 Phone: 812-283-5950 Fax: 812-285-5439 | |
Dr. Craig S. Kamen, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1214 Spring St, Suite 2, Jeffersonville, IN 47130 Phone: 812-283-5950 Fax: 812-285-5439 | |
Dr. Anthony K. Duncan, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1214 Spring St, Suite 2, Jeffersonville, IN 47130 Phone: 812-283-5950 Fax: 812-285-5439 | |
Dr. Kelly J. Colomb, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1214 Spring St, Suite 2, Jeffersonville, IN 47130 Phone: 812-283-5950 Fax: 812-285-5439 | |
Dr. David Rodriguez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1214 Spring St, Suite 2, Jeffersonville, IN 47130 Phone: 812-283-5950 Fax: 812-285-5439 |